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Cellular identity at the single-cell level
Ahmet F. Coskun,*a Umut Eserb and Saiful Islamc
A single cell creates surprising heterogeneity in a multicellular organism. While every organismal cell
shares almost an identical genome, molecular interactions in cells alter the use of DNA sequences to
modulate the gene of interest for specialization of cellular functions. Each cell gains a unique identity
through molecular coding across the DNA, RNA, and protein conversions. On the other hand, loss of
cellular identity leads to critical diseases such as cancer. Most cell identity dissection studies are based
on bulk molecular assays that mask diﬀerences in individual cells. To probe cell-to-cell variability in a
population, we discuss single cell approaches to decode the genetic, epigenetic, transcriptional, and
translational mechanisms for cell identity formation. In combination with molecular instructions, the
physical principles behind cell identity determination are examined. Deciphering and reprogramming
cellular types impact biology and medicine.
Introduction
Multicellular organismal life starts from a single cell and
experiences significant physiological and molecular changes
during development under dynamic environmental stimuli.
A human body is formed based on a single zygote cell that
creates more than 1013 specialized cells with unique subcellular
structures and complex functions after extensive cellular divi-
sion.1 Although individual cells in an organism share almost
indistinguishable genomic material, cellular proliferation and
diﬀerentiation lead to remarkable diversity that makes up
diﬀerent parts of organisms such as blood formation, neural
development, and organ growth (Fig. 1). Regulatory mecha-
nisms are considered to facilitate cellular specialization in
development across the central dogma covering deoxyribonucleic
acid (DNA), ribonucleic acid (RNA), and protein conversions.2
Genomic DNA content, messenger RNA expression, and protein
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abundance have been weakly correlated within biological
processes in cells.3,4 Besides, the molecular patterns that a cell
expresses are very dynamic and subject to change over time.
Thus, genetic information transfer from DNA to protein
exhibits significant heterogeneity and stochasticity, resulting
in a variety of cell fates and phenotypes that define specific
cell types.
Genome-wide DNA, RNA, and protein profiling methods
have elucidated potential regulatory mechanisms for cellular
diﬀerences.5,6 However, these approaches have been limited to
the ensemble average data that combine information from a
group of cells. The heterogeneity in cellular populations is
resolved by analyzing the regulatory elements in individual cells.
Thus, single cell technologies have received considerable atten-
tion to explore population architecture in organisms consisting
of various cellular subtypes. For example, emerging single-cell
RNA sequencing (RNA-seq) and single-cell quantitative poly-
merase chain reaction (q-PCR) techniques have mapped out the
molecular states of individual cells in both healthy and diseased
model systems. While cells have been classified based on gene
expression data in certain organisms, understanding global
regulation that gives rise to cellular identities requires sophisti-
cated analysis of epigenome, genome, and proteome landscapes
together in spatial and temporal domains.
Here, we discuss molecular coding mechanisms for cellular
identity formation especially covering genomic, epigenomic,
transcriptional, and translational regulation in cellular develop-
ment. We provide single cell approaches that have shed light on
some of these codes in development. In particular, we review
the observed cellular states using available single cell profiling
techniques. We then highlight the need for further advances in
single cell techniques. In addition to molecular programming,
we discuss the physical mechanisms leading to cell type forma-
tion. Finally, we overview some of the applications of cell identity
studies in biology and medicine.
Molecular coding
Recent advances in whole genome sequencing have revealed
that humans share 18–95% of a common genome with other
organisms such as worms, fruit flies, zebrafish, plants, dogs,
and mice.7–10 Similarities in their DNA sequences help these
organisms perform conserved cellular functions such as growth
and movement, among others. However, the DNA sequence
differences are primarily responsible for making each organism
unique with a special molecular make up and physical struc-
ture. Any two human beings are identical in 99.9% of their DNA
content.11 Despite this high degree of similarity, humans exhibit
significant differences between individuals in their physical
appearances and capabilities. Person-to-person variations may
arise from small sections of our DNA that contain only 0.1% of
Fig. 1 (a) Single zygote cell produces cellular diversity in a multicellular
organism in development. (b) One cell creates up to trillions of functional
cells. (c) A series of diﬀerentiation events create highly specialized cells.
(d) Microarray data show diﬀerent cell types from gene expression analysis
of 80 tissue samples. Colours represent distinct tissue types and each grey
dot denotes a gene expression data point for each tissue sample.
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the entire 6 billion base pairs corresponding to a significant
amount of ‘‘6 million’’ base pairs per cell.
In addition, mutations in DNA contribute to this diversity.
In humans, DNA polymerase fidelity is estimated to be about
108 per genomic site per generation. For a 6.6  109 base-pair
diploid genome, on average 60 mutations occur per cell
division.12–14 Everyone naturally contains hundreds of muta-
tions and most of them persist during the life span. Such a
significant mutation rate has an impact on human conditions
especially for diseases. In the human body, the DNA is almost
identical in every cell, but still many specialized cell types have
been produced within different tissues and organs (Fig. 1).
To shed light on cell identity formation, the following section
will discuss molecular coding mechanisms (Fig. 2) across the
central dogma of biology that lead to cellular specialization.
Genetic code
Cellular DNA contains genetic instructions for human traits
and transmits to the next generations through inheritance. All
of the cells inherit the same DNA from the germline cells, and
thus, the cells within an organism have almost the same DNA
sequences (exceptions are discussed in the next section). These
cells make use of an instruction manual, known as the genetic
code, to read the nucleotide sequence of a gene and construct a
corresponding protein structure. In particular, the code com-
prises a direct mapping of every triplet of nucleotides in a nucleic
acid sequence to a single amino acid.15 While the majority of
genes are encoded with exactly the canonical or standard genetic
code, there are many other variant or non-canonical codes.
Therefore, the genetic code is not universal and has continued
to expand its coding capacity throughout evolution.16,17 Such
naturally evolved genetic code in cells may play an important
role in the proteome balance, which might be critical for
survival functions. Despite recent evidence in genetic code
modifications, the cell identity formation is tightly linked to
the activation of subsets of genes through a presumed universal
genetic code. Simply, the DNA sequences are conserved,
but selective and specific use of DNA gives rise to diﬀerent cell
types in development.
Genomic code
Diﬀerent cells in an organism have minor diﬀerences in DNA
sequences due to genomic aberrations including somatic muta-
tions, single-nucleotide polymorphisms (SNPs), deletions, struc-
tural variants, and copy number variations (CNVs), and genetic
mosaicism.18 Additional genomic diﬀerences are prevalent in
immune cell types such as B-cells that modify a small part of
DNA to produce antibodies and some organisms with pro-
grammed DNA elimination.19 While normal development does
not phenotypically change with these small genomic variations,
cancer formation is partially attributed to these mutations.20
Whole genome amplification and sequencing methods have
been developed to access these genomic variations in diseases
such as neurological disorders.21
Chromosomal conformation code
The human genome is hierarchically organized in three dimen-
sions (3D) leading to a fractal globular shape in the nucleus.22
Diﬀerent juxtapositions of transcription factories, enhancers,
and promoters interact with each other in physical space, giving
rise to diﬀerential expression patterns.23,24 Such variation in
chromosomal conformation is not only found among diﬀerent
organisms, but is also observed among diﬀerent tissues of the
same organism. Distinct cell types exhibit unique 3D chromatin
structures and genome topology. Specifically, topologically
associated domains (TADs) control physical interactions of
genomic elements (enhancers and promoters) to regulate geno-
mic activity. TADs determine distinct 3D chromosome struc-
tures based on the cell type origin.25 Altering the structure of
TADs and boundaries can lead to diseases.24 Notably, 3D genome
structure modifications play a central role in cell identity deter-
mination for other mechanisms such as transcriptional and
epigenetic control, the details of which will be expanded in the
following sections.
Transcriptional code
In the quest for determining their fates, cells combine cascaded
messages coming from signaling networks and transcriptional
regulators to decide which set of genes to express. Specifically,
cell identity is formed through the interplay between transcrip-
tional factors and environmental stimulation such as Notch
signaling in immune cell development or Shh signaling in
central nervous system development.26–29 Transcription factors
play a role as activators or repressors of gene expression in
developing organs. Cell types express a specific set of transcrip-
tion factors as a barcode identifier for a cell. Thus, combinatorial
transcription regulation lies at the heart of developmental
processes in organisms. For instance, an appropriate combi-
nation of transcription factors (Brn2, Ascl1, Mytl1, and Neurod1)
is sufficient to reprogram fibroblasts to other cell types such
as neurons.30
In the DNA–protein association data by Chromatin immuno-
precipitation followed by sequencing (ChIP Seq), transcription
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factors typically bind to cis-acting or trans-acting regulatory
elements known as enhancers to regulate gene expression.31,32
Enhancers can be shared by multiple transcriptional factors and
exhibit cell type specific distribution. Therefore, transcriptional
enhancers contribute to the selection of cell fates. Master
transcriptional factors form clusters of enhancers, which are
referred to as super-enhancers.33,34 Chromosome 3D local struc-
tures control super-enhancer driven cell identity formation.
Specifically, local chromosome loops contribute to the insulation
of neighbouring genes. In addition, cancer cells form super
enhancers for oncogenes.35 While the concept of super enhancers
is relatively new and requires substantial validation, their
emerging role may be important in cell identity both in health
and disease.36
Epigenetic code
A complementary mechanism to the interplay of local regula-
tory DNA sequence and transcription factors, by orchestrating
the gene expression through the changing state of the chroma-
tin, is called epigenetics.37 Epigenetic code primarily researches
the roles of DNA packaging histone proteins and chemical
modification of the nucleotides such as DNA methylation.38
Compared to universal genetic code, epigenetic codes exhibit
cell type specific regulation, providing a critical component of
cell identity studies.
Histone code is an epigenetic factor that partly changes
transcription by chemical modifications to histone proteins.39–42
Combinations of covalent histone modifications such as methyl-
ation, acetylation, phosphorylation, and ubiquitination recruit
other specific proteins to modify the chromatin structure,
causing activation or repression of a gene. Enhancers in human
genome are significantly marked by histone modifications in
distinct cells to enable cell type specific gene expression.43 To
maintain the cell identity against variations of the stochastic
environment, histone modifications such as H3K4me3 consis-
tently mark the key cell identity genes in specific tissues.44
Polycomb-group (PcG) protein complexes catalyse histone modi-
fications to silence transcription in embryonic development.45–48
Epigenetic PcG repression plays an important role for stem cells
in health and disease such as cancer.
DNA methylation adds to the modularity of epigenetics to
aﬀect cell type specific gene expression.49 Covalent addition of
a methyl group to the cytosine across the genome causes
diﬀerential regulation in the adjacent genes.50 For instance,
pancreatic b cell identity is controlled by the repression of an
aristaless-related homeobox (Arx) gene through the DNA methyl-
ation mechanism.51
Non-coding DNA sequences such as transposable elements
have an impact on cell type specific transcriptional activity. These
mobile DNA pieces move around the DNA genome. In particular,
L1 retrotransposition, a mechanism in which reverse transcribed
elements are inserted into the genome, exhibits diﬀerential
regulation in germ cells, stem cells, and neuronal cells.52–57
Another epigenetic modulator is non-coding RNAs in cells.
Long non-coding RNAs (lncRNAs) play an important role in
reprogramming mammalian cells.58–60 Human tissues exhibited
cell specific expression of lncRNAs in b cells. A mesoderm
specific Fendrr lncRNA provided tissue specific expression in
heart and body wall development. lncRNAs appear to be crucial
gene expression regulators by affecting nuclear organization
and sequestering microRNAs (miRNAs), behaving as miRNA
sponges.61–65 In addition, microRNAs are short non-coding
RNAs that can manipulate the expression of genes to modulate
the differentiation status of cell identity.66 miRNAs cooperate to
silence target mRNAs.67 Another class of small RNAs includes
Piwi interacting RNAs (piRNAs) that repress the activity of
retrotransposons especially in somatic and germline stem
cells.68,69 piRNAs control lineage determination in multiple cell
types within the Drosophila ovary.70
While the term ‘‘code’’ for epigenetic modifications has been
widely used in cell biology, it is still at the level of hypothesis and
begs the question for concrete evidence. Current observables
have been limited to correlations. For example, H3K36me3 is
associated with gene expression at the 30 end of the genes.
However, there are cases where the gene is not expressed and
still H3K36me3 was pronounced, or alternatively, the gene is
active but H3K36me3 was not detected in cellular machineries.
Besides, the majority of these histone marks correlate highly
with each other, raising the issue of whether those are determi-
nants; or, just marks of the DNA state; or which ones are the
determinants.
RNA code
RNA processing of the nucleotide sequence aﬀects cell identity.
Both co-transcriptional and post-transcriptional regulation mecha-
nisms of gene expression are controlled by alternative splicing
events. Splicing of a transcript exhibits cell type specific regula-
tion diﬀerences to perform specialized functions in diﬀeren-
tiated cells.71–74 Moreover, an alternatively spliced transcript
can produce diverse proteins, which interact with a different set
of proteins as if they originated from different genes.75 Cells
acquire splicing code based on the developmental context
(sex, age, function, and organism) to obtain the necessary diverse
protein landscape for cellular functions.
RNA editing is another post-transcriptional modification of
RNA molecules to change the nucleotides on the transcripts.
It is a rare alteration that has been observed in neuronal cell
identity development.76 In particular, adenosine-to-inosine
editing in RNAs creates protein isoforms for creating neural
excitability diﬀerences.77 14 human cell lines exhibited diﬀerences
in their RNA editing patterns.78 Tissue specific RNA editing
was mapped out by a computational tool (GIREMI).79 The
APOBEC3A gene facilitates RNA editing events in macrophages
and monocytes.80
Translational code
The ribosomal machinery has classically been considered to
act constitutively in the translation of mRNAs to proteins.
However, there is increasing evidence to support a specialized
ribosome theory that exhibits transcript specific regulation in
development.81 Thus, a ribosome-mediated regulationmechanism82
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that unique ribosomes with structural and functional diﬀer-
ences may prefer translation of subsets of mRNAs in diﬀerent
cell types. Ribosomal compositional variations (composed of
4 ribosomal RNAs and 80 proteins) have recently been measured
by mass spectroscopy to reveal diﬀerential stoichiometry among
ribosomal proteins.83
Protein code
While transcriptional and translational mechanisms encode
proteins, the dynamic regulation of proteins to perform specific
cellular functions is guided by post-translational modifications
such as phosphorylation, among more than 200 others. For
instance, cells utilize such modifications of proteins to main-
tain the body’s circadian clock and basic cell division tasks, as
well as to avoid cancer formation.84–86 Thus, protein modifica-
tions are critical for regulatory specificity in differentiated and
specialized cells.
Proteins must be folded properly and pass the quality control
in a cell.87 Aggregation of misfolded proteins causes a loss of cell
identity, increasing the prevalence of critical diseases such as
cancer. Next, protein–protein interactions experience cell type
specificity to obtain distinct cellular identities. For instance, LIM
factor Lhx3 binds to LIM cofactor NLI to stimulate interneuron
specification in development.88 Protein complexes indirectly
repress the activity of a transcriptional factor to guide the
selection of a neuronal fate.
Single cell decoding
Powerful genome wide DNA/RNA sequencing technologies
have successfully mapped out molecular codes for cell identity
formation.5,6 However, the presented approaches can only
provide ensemble data. Sub-population biological studies have
been lacking due to these sequencing limitations. The non-
uniform distribution of molecular components across the popula-
tion might be critical to understand how cells reach a fate in a
multicellular system (Fig. 3). Besides, gene expression levels exhibit
significant variability in cells due to multiple regulatory mecha-
nisms as previously discussed in the molecular coding section.89
Here, we discuss the identification of cellular identity based on
single cell molecular profiling techniques from the genome to the
proteome scale.
Single cell genomics
Nucleotide variants in the genome lead to diﬀerent cellular
functions. Mainly, somatic mutations cause nucleotide variants
that accumulate in the genome of a single-cell over several
divisions. Even though somatic variations are routinely prevalent
in diseased and normal tissues, the rate of somatic variations is
unexpectedly high.90,91 These mutations give each cell a unique
identity with poorly defined functions. Thus, to decipher the role
of dynamic mutations in cellular functions, single cell whole
genome sequencing technologies reveal previously obscured
variability and complexity in the genetic factors leading to those
mutations. Multiple types of variations occur in gene function
due to the burst size and frequency in gene expression, as well as
cell cycle diﬀerences. To access the genome diﬀerences of each
cell, DNA sequencing of single cell materials requires whole
genome amplification methods such as the PCR based method,
the multiple annealing and looping based amplification
(MALBAC) isothermal method, and multiple displacement
amplification (MDA). Microarrays and next generation sequenc-
ing then process the resultant amplified material to map out
genomic variations in individual cells. Sequencing single sperm
cells revealed higher mutation rates compared to the previous
population measurements.92 This suggested genomic vulner-
ability within the first cellular divisions. Sequencing in single
cancer cells revealed unique phases of tumour evolution based
on copy number variation dynamics.93 Bioinformatics analysis
of CNVs within individual cells mapped out the phylogenetic
trees of developing cells within organisms.94 Somatic CNVs
were detected in human brain health and disease.95 Accumula-
tion of somatic mutations in developing human neurons was
also tracked using single cell DNA sequencing.96
Single cell transcriptomics
Sequencing and imaging technologies have facilitated the
quantification of mRNA molecules within a cellular volume.
Unlike the fixed nature of DNA, RNA levels fluctuate in cells in
response to stimuli. Thus, transcript measurements provide
functionality of a single cell. Reverse transcription and whole-
transcriptome amplification schemes enabled microarrays,
quantitative PCR, and next generation sequencing (NGS) ana-
lysis for sequencing approaches at the single cell sensitivity.
Transcripts from picograms (pg) of cellular RNA material are
typically converted to complementary DNA (cDNA) during
amplification to enable RNA sequencing read out.97,98 Recently,
the reverse transcription step has been modified by an ampli-
fication step of a cDNA library together with adapter processing
(tagmentation).99 Despite this common cDNA usage feature,
current single cell transcriptomics approaches diﬀer based on
their cell capturing strategies, targeting sites of a transcript
(end vs. full length), quantitative counting capabilities (absolute
or not), and strand specificity.100 RNA sequencing methods
have shed light on transcriptional codes within individual cells.
Fig. 3 Distinct cell types have unique physical and molecular signatures.
Single cell molecular profiling provides the identity of each individual
cell. Despite common DNA sequences, protein (colour filled circles) and
genome (grey) interactions create a heterogenous distribution of RNAs
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These high-resolution transcriptional profiles of single cells
reveal key population parameters such as the distinct cell types
and subtypes, additional biomarkers per cell identity, and gene
regulation modes observed in a new subpopulation (Fig. 4).
Cell type classification. While traditionally cells have decently
been classified based on structure and function, the optimal cell
type determination approach is to utilize underlying gene regu-
lators and their connections.101,102 Therefore, single cell mole-
cular profiles are paramount for the identification of distinct cell
types within heterogenous cell populations. Similarity in the
transcriptional states of individual cells is utilized to extract
common molecular signatures for a cell type. Generally, cells
are classified by computational analyses of single cell RNA
sequencing results using data presentation and reduction algo-
rithms. Specifically, distinct clusters are obtained on hierarchical
clustering heat map and principle component analysis plots,
among many others. Currently, many cell-typing studies have
been performed in one organ at a time.103–113 Using 96 to 44 000
and more cells, RNA sequencing methods have identified 3–47
and more cell types in different organs (Table 1). Covering all the
organs would extend mapping of all the cell types within an
organism to pave the way for a human atlas at cellular resolution.
Besides, single-cell transcriptome studies provide differences in
healthy and diseased cell states within individuals.
Biomarker discovery. Highly sensitive and specific bio-
markers are needed to define the cellular states in health and
disease.114,115 Together with conventional protein and nucleic
acid labelling methods, DNA/RNA sequencing information
about individual cells expands the toolset of testable molecular
biomarkers. Single cell transcriptional profiles mapped out
previously undetected biomarkers in the colon, the lungs,
the intestine, and the tonsil organs.103,104,106,110 In particular,
the identification of biomarkers for immune cells significantly
benefits from single-cell analysis. To identify markers, high
expression levels of specific genes yielded distinct clusters in
gene expression maps. For instance, transcriptional profiles of
4 distinct cell populations in the innate lymphoid cells (ILCs)
revealed new markers in each cellular group such as GATA3 in
ILC2 and RORC in ILC3 cells.110 These molecular identifiers are
used for studies of homeostatic and inflammation conditions.
Single cell transcriptional profiles allowed the identification of
novel markers that were previously masked in population level
measurements. Besides, single cell analysis of immune cells
provides a T cell receptor repertoire that is developed against
a specific infection.116 To map out the antigen diversity, the
single cell transcriptomics approach yields clonally expanded
T cell receptors for therapeutic applications and vaccination
development.
Rewiring gene regulatory networks. Combinations of transcrip-
tion factors interact with a genomic portion of DNA sequence
clusters, and, at the same time, each transcription factor interacts
with multiple genomic regions to regulate developmental pro-
cesses, creating a gene regulatory network (GRN).117 Although
genome-wide DNA/RNA sequencing provided significant GRN
details, single cell transcriptional results have provided previously
unrecognized regulatory relationships in the development of
diﬀerent cell types including blood cells.118–120 Single cell analysis
has significant potential to dissect subpopulation architecture
expressing combinations of genes that were obscured in the
ensemble sequencing data. GRNs are much more complex when
the cells differentiate into other cell types. Single cell analysis of
120 cells at 8 distinct time points during differentiation from
human myeloid monocytic leukemia cells to macrophages
revealed dynamic and specific rewiring.121
Noncoding transcript dynamics. Single cell transcriptional
profiling by RNA sequencing revealed the dynamic role of
lncRNAs in cellular programming. Specifically, lncRNAmolecules
regulate metabolic gene expression and repress lineage-specific
genes.122 Single cell RNA fluorescent in situ hybridization (FISH)
measurements on 61 distinct lncRNAs within three diﬀerent cell
types yielded abundance and subcellular localization patterns.123
Fig. 4 Single cell profiling yields insights into cellular populations. These
advantages include cell type discovery (T1 and T2 distinct cells with unique
molecular content), subpopulation architecture identification (S denotes an
emerging cellular subgroup), biomarker discovery (A–C and C–E are new
identifiers of cells), and gene regulatory network refinement (red arrow
shows previously undetected regulation partners).
Table 1 Transcriptional profiles of single cells are used to define cell
identities and states in distinct organs. RNA sequencing identified similar
cells based on computational analyses of transcriptional data. Previously
unknown cell types, biomarkers, and developmental cues were observed
from the single cell data
Specimen Method Throughput Result
Colon103 PCR 96 5 cell types, 2 markers
Lungs104 RNA-seq 198 Cell marker identification
Brain105 RNA-seq 3000 47 subclasses
Intestine106 RNA-seq 238 3 subtypes, 1 marker
Spleen107 RNA-seq 4000 Immune cell types
Bone marrow108 RNA-seq 2730 Early commitment
Glioblastoma109 RNA-seq 430 Multiple subtypes
Tonsil110 RNA-seq 648 Biomarker discovery
Neuron111 RNA-seq 622 11 cell types
Retina112 Drop-seq 44 000 39 cell types
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Most of the lncRNAs are localized to the nucleus with signifi-
cant cell-to-cell variability, while some are spread across the
cytoplasm similar to mRNA localization patterns. Another set
of RNA sequencing measurements within individual oocytes
showed that the lack of miRNA and small interfering RNA
(siRNA) controlling genes (Dicer1 and Ago2) abnormally
upregulated another 1696 and 1553 genes, respectively.124
Recently, single-cell analysis in the neocortex of the human
brain revealed that lncRNAs are richly expressed in certain cell
types in brain samples, which were previously masked by bulk
studies.125 These findings showed lncRNA’s unique functions
in specific cell types within the brain, creating distinct brain
cell identities.
Transcript variant detection. RNA sequencing and FISH
validation experiments on bone-marrow-derived individual
dendritic cells provided heterogenous protein isoforms.126 During
the embryonic developmental stages, spanning the zygote to late
blastocyst stages, unique splicing patterns were obtained per
cell.127 Two or more transcript isoforms of the same gene were
observed in single cells, creating dynamic patterns of alternative
splicing in human embryos and embryonic stem cells. Another
statistical analysis method on RNA sequencing results showed the
link between the cell cycle and alternative splicing.128
Probing ribosome code. Dense transcripts for ribosomal
proteins (typically found in the ribosomal subunits) weremapped
out in cultures and thymus tissue sections, revealing cell type
specific gene expression in single cells.129 This observation
supports the specialized ribosome theory as a cell identity
regulator through the control of translational machinery. Two
open questions would illuminate the ribosome code hypothesis
at the single cell level. First, simultaneous profiling of ribosomal
protein genes and metabolism related genes to test the role of the
ribosome structure in transcript-specific translation within single
cells. Next, mapping out directly ribosomal proteins (instead of
the corresponding RNA molecules) to address the potential
questions due to the short lifetime of RNAs. The RNA versus
protein measurement concern holds for the single cell biology
field in general, which should be taken into account also for cell
identity studies.
Spatial mapping. While conventional RNA-seq achieves
decent spatial resolution, imaging based in situ RNA profiling
techniques provide spatial organization of cellular identities
at the single-cell and single-molecule resolution. Spatially
resolved RNA-seq (Tomo-seq) identified the role of BMP signal-
ling in cardiomycote regeneration with coarse 3D mapping of a
zebrafish heart, which was limited to large sample to sample
collection distances.130 On the other hand, in situ RNA sequenc-
ing approaches yield spatial distributions of molecules within
a single cell or across multiple cells.131–134 Most in situ
RNA detection methods are limited to flat cellular layers;
however, signal amplification methods have been developed
to screen transcriptional states of cellular types in thick tissue
samples.135–137 The spatial arrangement of cells provides
opportunities to study interactions of different cell types for
the deconstruction of complex tissue and organ formation in
development.
Single cell epigenomics
While most cellular identity results are from genomics and
transcriptomics data, recent eﬀorts in single cell epigenomics
have started to shed light on cell type specific regulations.
Single cell bisulfate sequencing has been developed for map-
ping DNA methylation across the genome within individual
cells. Recent demonstrations revealed epigenetic diversity
and dynamics in embryonic stem cells.138,139 Complementary
imaging approaches screen a few epigenomic marks at a time.
For instance, histone modifications have been detected by a
proximity ligation assay in single cells. In particular, smooth
muscle cells exhibited lineage specific dimethylation of lysine 4
of histone H3 (H3K4me2) in the Myh11 locus in individual cells
within tissue sections.140 Live imaging of reporter assays pro-
vided in vivo regulation of DNA methylation patterns in indi-
vidual cells.141 Another reporter assay showed the eﬀect of
epigenetic modifications on transcriptional activity.142 Another
form of DNA methylation variant 5hmC (5-hydroxymethylcytosine)
was recently sequenced at the single cell level. Based on the
glucosylation-dependent digestion of DNA, 5hmC cell-to-cell varia-
tions were obtained and used for lineage reconstruction in mouse
embryos.143
Integration of advanced imaging, microfluidics, and barcoding
enables a single cell ChIP-Seqmethod tomap out chromatin states
in individual cells. Despite its low coverage, diﬀerent embryonic
stem cells exhibited heterogeneous chromatin profiles.144 Another
low input ChIP-Seq was devised to measure histone mark profiles
in individual cells.145
Simultaneous measurements of the methylome and tran-
scriptome of the same individual cells show the link between
DNA methylation and transcription. Previously unrecognized
heterogeneity of methylation in distal regulatory elements
contributed to the transcriptional activity of pluripotency genes
in embryonic stem cells (ESCs).146 After obtaining substantial
results compared to standalone bisulfite sequencing, this
approach validated the correlation of the methylation patterns of
non-CpG island (CGI) promoters with transcriptional repression.
These results suggested significant epigenetic heterogeneity from
cell to cell, especially in pluripotency factors such as Esrrb within
serum ESCs.
Single cell proteomics
The protein content of an individual cell indicates its ultimate
functional state. Powerful microscopy, flow cytometry,147 and
mass spectroscopy,148 microarrays,149 and immuno-PCR150
techniques benefited from antibody labelled single cell assays
to profile proteins. Antibody–oligonucleotide conjugate arrays
within microfluidic chips enabled the highly multiplexed detection
of proteins in single cells.151,152 Next generation sequencing enabled
the detection of ligation assay based protein detection.153,154
Antibody tags exhibit specificity issues and are challenging to
engineer for all proteins. To improve specific detection, the
single cell western blot technique was developed to multiplex
proteins within mammalian cells.155 Rapid progress in proteomic
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Single cell chromosome-conformation-capture
As the physical conformation of the chromosome influences
the gene expression and eventually the cell fate, the single-cell
Hi-C technique is developed to provide a probe of the cell-to-cell
organizational variation of the genome.157,158 Recently, the 4D
Nucleome project, a National Institute of Health (NIH) funded
consortium, has aimed to decipher the relationships between
chromosomal conformation, tissue types, and diseases.
Physical mechanisms
The systems biology view of cell identity formation expanded
our knowledge on coding mechanisms even down to single cell
levels. However, cells make decisions under realistic physical
factors to reach unique identities. To dissect the physical princi-
ples behind cellular specialization, we discuss the internal and
external influencers that play a role in a cell’s coordination and
cooperation in development.
Intracellular
Molecular conversions within an individual cell are guided by
physical rules. Investigation of the governing physical mecha-
nisms in diﬀerent cell types is crucial to understand how
cellular identity is formed and properly maintained in health.
Kinetic proofreading. The genetic code encompasses specific
recognition of transfer RNAs (tRNAs) to match anticodons to
codons in mRNAs. The error rate in this process is 1 in 10000,
enabling correct protein synthesis practically all the time to form
appropriate cellular identities. Despite the existence of other similar
sized molecules, specific molecular interactions achieve proper
assembly with low erroneous molecular recognition. Therefore,
cells do not get aﬀected by thermodynamic noise in gene transla-
tion owing to a kinetic proofreading (KP) mechanism. Proposed by
John Hopfield, KP incorporates multiple selection steps to enrich
correct binding. Incorrect conjugation still occurs but falls oﬀ
before aﬀecting the process.159,160 KP is also a general mechanism
in cells to increase the specificity of molecular binding events
including cell-to-cell interactions. For instance, blood cells utilize
KP to recognize antigen-presenting cells in our immune system.
DNA–protein interactions. Different transcriptional programs
in cells are regulated by interactions of proteins with DNA, leading
to activation or repression of gene expression. Combinations of
multiple transcription factors create cell specific transcriptional
programming in both prokaryotes and eukaryotes.161 The binding
events of TFs are often modelled by thermodynamics principles. A
simple TF–DNA interaction models the total binding energies and
binding probability of a TF to its target.162 The promoter archi-
tecture of each gene includes activators and repressors to regulate
gene expression. A general formalism was developed to take
into account the binding strength and abundance of these
regulators. This approach linked physical parameters of tran-
scriptional regulation fugacity to the fold-change (FC) in gene
expression.163
Chromatin structure. Another physical mechanism is that
epigenetic codes change the gene expression by modifying the
structural distribution of chromatin.164 Sequential histone
modifications silence gene expression by compacting chromatin
to form a heterochromatin.165 A change in the structure of
chromatin also allows the recruitment of other proteins.166,167
An analytical model was developed to investigate a few histone
modifications.168 DNA methylation increases the rigidity of the
chromatin structure and disfavours the positioning of nucleo-
somes on DNA.169,170
Splicing entropy. RNA maturation process includes the
assembly of gene products through splicing machinery. Aberrant
RNA types are formed in diseases such as cancer. This disorder is
modelled by Shannon’s entropy.171–173 Cancer cells exhibited
highly significant splicing disorder compared to healthy subjects.
Extracellular
Cells make decisions under environmental factors such as
signalling molecules, extracellular matrix (ECM) contexts, mecha-
nical features, and interaction with other cells.174 Cell’s morphol-
ogical characteristics such as shape, ECM’s stiﬀness and
topography are themain physical regulators to aﬀect cell’s identity
development.175 Stem cells sense the properties of an ECM by
feedback signalling from mechanical and biochemical cues.176
Engineering niches for stem cell studies will open up new direc-
tions in cellular reprogramming and tissue regeneration.177
Applications
Research
Single cell approaches yield rich data to decipher complex bio-
logical networks in organisms with molecular sensitivity. These
detailed cellular data are highly valuable for systems biology
research. In particular, measuring gene products allows the
development of cell specific mathematical models to describe
biological information processing in single cells.178,179 These
outcomes reveal a network of molecular components (nucleic
acids and proteins) to formulate and test hypotheses in cellular
machineries. Complementary implementation of single cell studies
in medical settings facilitates systems medicine research to
reconstruct biological networks in health and disease for transla-
tional purposes, paving the way for personalized and predictive
medicine.180–183 These emerging directions provide opportunities
to understand molecular principles of diseases and determine the
best drug screening strategies in single cells. Primarily, cancer
research leverages emerging single cell sequencing methods
to study the molecular mechanisms of tumor heterogeneity,
evolution, evasion, metastasis, and resistance.184,185 Single cell
DNA/RNA sequencing in primary sites and circulating tumor
cells revealed copy number variations, mutation rates, clonal
dynamics, and transcriptional mapping within various cancer
types including pancreatic, breast, lung, colon, and bladder
cancers, and melanoma.
Diagnostics
Early screening and detection of diseases including cancer is
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techniques such as transcript profiling allowed biomarker
discovery in disease to develop diagnostic assays. Bodily fluids
such as human saliva were used as a non-invasive diagnostic
method to define a set of biomarker signatures for early
detection.186 Transcriptomic biomarkers made it possible to
diﬀerentiate lung cancer patients from normal subjects with high
sensitivity and specificity. Similarly, a liquid biopsy method
utilized single cell sequencing to profile circulating tumour cells
in breast cancers.187 Single cell genotyping revealed heterogenous
mutations in acute myeloid leukaemia (AML).188 In AML samples,
deciphering the distribution of FLT3 and NPM1 mutations in
clonal populations suggested significant tumor variability for
better diagnosis and potentially for monitoring the progression
of disease.
Therapeutics
The ultimate therapy should be to use patient derived induced
pluripotent stem cells (iPS) for reprogramming to any cell type
of interest towards a specific disorder. For instance, molecular
changes during reprogramming from fibroblast to neurons
have been dissected by single-cell RNA-seq.189 This approach has
been tested in medical settings for hematological, neurological,
cardiovascular, metabolic, endocrine, and muscular disorders,
yielding insights into drug based therapies.190,191 Reprogramming
therapies included sickle cell anaemia treatment in mice by
correcting mutations in hematopoietic stem cells followed by
transplantation.192 Transferring iPS technology to correct human
diseases is promising, but many challenges in complex molecular
engineering eﬀorts covering transcriptional and epigenetic regula-
tions and gene editing approaches need to be addressed to realize
stem cell based therapies.193
Discussion
Multiple layers of regulators from chromatin states to post-
translational modifications contribute to the cellular identity.
The interconnection between these layers presents challenges
to dissect the roles of each player. Hence, the ultimate goal is
to merge studies of molecular decoding from diﬀerent levels
of gene control mechanisms. Simultaneous profiling of the
genome, transcriptome, epigenome, and proteome has signifi-
cant potential to reveal cell identity formation. Currently, the
genome and transcriptome have been probed even in the same
individual cell.194,195 Increasing eﬀorts measure single cell
correlations of transcripts and proteins.196,197
Coverage in single cell sequencing is limited compared to
bulk DNA/RNA sequencing due to amplification errors (allelic
dropouts, distortion, false positive rates, and non-uniform usage)
and small sample volumes. Mapping the entire genome (100%
coverage) needs technological advancements to reduce sequence
dropout errors, which can then accurately measure mutations
without being aﬀected by experimental noise. Increasing eﬀorts
such as MALBAC and MDA have improved the coverage levels of
DNA sequencing to more than 90% in individual cells.198–202 On
the other hand, current RNA sequencing methods have 5–25%
detection efficiency due to the poor conversion of RNAs to cDNA
and eventually to amplified sequences. Reducing the reaction
volume (from microliters to nanoliters within microfluidic
chambers) captures more RNA molecules.90 Alternative bio-
chemical strategies are needed to enhance the RNA/cDNA
conversion rate for efficient RNA sequencing approaches.
Besides, to cover the entire proteome at the single cell level,
efficient labelling strategies are desired to identify each and
every protein in complex tissues and organs. Profiling other
molecules (metabolites, lipids, small molecules, non-coding
RNAs, among others) would complement existing single cell
analysis techniques.
Conclusion
The presented cellular identity study will transform develop-
mental biology research with a particular emphasis on the
integration of systems level molecular analyses and underlying
physical exploration. Understanding diﬀerent levels of molecular
coding at the single cell level will explain how cellular identity is
gained in health and lost in disease. Physical control mecha-
nisms will explain how cells specialize under many environmental
stimulants. Finally, defining the cell state and reprogramming the
cell identity will revolutionize medical research and practice.
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